Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Woo-Kyung Chung"'
Publikováno v:
Molecules, Vol 29, Iss 1, p 165 (2023)
The antibacterial activity and mechanism of Pinus densiflora extracts against Escherichia coli and Staphylococcus aureus were investigated. The growth inhibition tests of paper diffusion and optical density exhibited that the extracts have potent ant
Externí odkaz:
https://doaj.org/article/61ea3270f0bc4cb2843238ce627b0fe9
Autor:
Hyun-Jin Kim, Hyun-A Shin, Woo-Kyung Chung, Ae-Son Om, Areum Jeon, Eun-Kyung Kang, Wen An, Ju-Seop Kang
Publikováno v:
Biomedicines, Vol 11, Iss 12, p 3121 (2023)
This study aimed to elucidate the unique chemical compositions of plasma-activated water (PAW) and the potential antibacterial efficacy of PAW as a novel vaginal cleanser. We analyzed the ion compositions (four anions: F−, Cl−, NO3−, SO42−; f
Externí odkaz:
https://doaj.org/article/917d8baf12ce445ca34070f7e35b1a63
Autor:
Chang-Yun Yoon, Yung Ly Kim, Seung Hyeok Han, Tae-Hyun Yoo, Su-Ah Sung, Woo-kyung Chung, Dong-Wan Chae, Yong-Soo Kim, Curie Ahn, Kyu Hun Choi
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 8, Iss 1, Pp 1-10 (2016)
Abstract Background In patients with chronic kidney disease, metabolic syndrome has been demonstrated to be the culprit behind diverse complications. Adiponectin is known to have anti-atherogenic and cardio-protective effects. Meanwhile, the relation
Externí odkaz:
https://doaj.org/article/2a45f65b83df45ada0bacd760a56b690
Publikováno v:
Translational & Clinical Pharmacology. Mar2024, Vol. 32 Issue 1, p30-40. 11p.
Publikováno v:
Translational & Clinical Pharmacology; Sep2024, Vol. 32 Issue 3, p127-136, 10p
Autor:
Woo Kyung Chung, Inyoung Hwang, Byungwook Kim, Jihyun Jung, Kyung‐Sang Yu, In‐Jin Jang, Jaeseong Oh
Publikováno v:
Clinical and Translational Science. 16:512-523
Valbenazine is a selective vesicular monoamine transporter 2 (VMAT2) inhibitor approved for tardive dyskinesia treatment by the U.S. Food and Drug Administration; its major active metabolite (NBI-98782) is a 45-fold more potent inhibitor of VMAT2 tha
Publikováno v:
Translational & Clinical Pharmacology; Mar2024, Vol. 32 Issue 1, p41-51, 11p
Publikováno v:
Investigative Radiology; Mar2024, Vol. 59 Issue 3, p252-258, 7p
Autor:
Hee Byung, Koh, Hyung Woo, Kim, Chan-Young, Jung, Yaeji, Lee, Jung Tak, Park, Tae-Hyun, Yoo, Shin-Wook, Kang, Joongyub, Lee, Yeong Hoon, Kim, Dong-Wan, Chae, Woo Kyung, Chung, Kook-Hwan, Oh, Seung Hyeok, Han, Sil-Hea, Sung
Publikováno v:
Journal of nephrology.
Many trials have attempted to slow the progression of chronic kidney disease (CKD) by modifying specific risk factors, but without achieving satisfactory results. We aimed to evaluate the association between the degree of improvement in multiple risk
Autor:
Woo Kyung Chung, Ji Yong Jung, Hyun Hee Lee, Jae Hyun Chang, Han Ro, Yong Hoon Shin, Ae Jin Kim
Publikováno v:
Experimental and Clinical Transplantation. 19:736-738
Posttransplant diabetes mellitus, presenile deafness, and myopathy are not commonly accompanied symptoms after kidney transplant. We report the case of a 48-year-old woman with diabetes mellitus, sensorineural hearing loss, and severe myopathy withou